136 related articles for article (PubMed ID: 20210346)
21. Chemotherapy resistance of glioblastoma stem cells.
Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
[No Abstract] [Full Text] [Related]
22. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
23. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier.
Tilloy S; Monnaert V; Fenart L; Bricout H; Cecchelli R; Monflier E
Bioorg Med Chem Lett; 2006 Apr; 16(8):2154-7. PubMed ID: 16464592
[TBL] [Abstract][Full Text] [Related]
24. Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
Thomadaki H; Mavridis K; Talieri M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):373-80. PubMed ID: 19190824
[TBL] [Abstract][Full Text] [Related]
25. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery.
Adenot M; Merida P; Lahana R
Chemotherapy; 2007; 53(1):73-6. PubMed ID: 17202815
[TBL] [Abstract][Full Text] [Related]
26. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
27. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
[TBL] [Abstract][Full Text] [Related]
28. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
29. Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30.
Wan JM; Sit WH; Louie JC
Int J Oncol; 2008 Mar; 32(3):689-99. PubMed ID: 18292947
[TBL] [Abstract][Full Text] [Related]
30. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
Emanuel SL; Hughes TV; Adams M; Rugg CA; Fuentes-Pesquera A; Connolly PJ; Pandey N; Moreno-Mazza S; Butler J; Borowski V; Middleton SA; Gruninger RH; Story JR; Napier C; Hollister B; Greenberger LM
Mol Pharmacol; 2008 Feb; 73(2):338-48. PubMed ID: 17975007
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole.
Howell SB; Hom D; Sanga R; Vick JS; Abramson IS
Cancer Res; 1989 Jun; 49(12):3178-83. PubMed ID: 2720673
[TBL] [Abstract][Full Text] [Related]
32. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
Spigelman MK; Zappulla RA; Strauchen JA; Feuer EJ; Johnson J; Goldsmith SJ; Malis LI; Holland JF
Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
[TBL] [Abstract][Full Text] [Related]
33. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
34. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
35. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.
Nonaka N; Shioda S; Niehoff ML; Banks WA
J Pharmacol Exp Ther; 2003 Sep; 306(3):948-53. PubMed ID: 12750431
[TBL] [Abstract][Full Text] [Related]
36. Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy.
Harris LN; Yang L; Liotcheva V; Pauli S; Iglehart JD; Colvin OM; Hsieh TS
Clin Cancer Res; 2001 Jun; 7(6):1497-504. PubMed ID: 11410482
[TBL] [Abstract][Full Text] [Related]
37. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.
Hau P; Fabel K; Baumgart U; Rümmele P; Grauer O; Bock A; Dietmaier C; Dietmaier W; Dietrich J; Dudel C; Hübner F; Jauch T; Drechsel E; Kleiter I; Wismeth C; Zellner A; Brawanski A; Steinbrecher A; Marienhagen J; Bogdahn U
Cancer; 2004 Mar; 100(6):1199-207. PubMed ID: 15022287
[TBL] [Abstract][Full Text] [Related]
38. PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.
Wong BK; DeFeo-Jones D; Jones RE; Garsky VM; Feng DM; Oliff A; Chiba M; Ellis JD; Lin JH
Drug Metab Dispos; 2001 Mar; 29(3):313-8. PubMed ID: 11181501
[TBL] [Abstract][Full Text] [Related]
39. Multi-functional peptide-modified liposomes for treatment of glioma.
Park K
J Control Release; 2018 Nov; 289():171. PubMed ID: 30724172
[No Abstract] [Full Text] [Related]
40. Targeted delivery of doxorubicin to mitochondria.
Chamberlain GR; Tulumello DV; Kelley SO
ACS Chem Biol; 2013 Jul; 8(7):1389-95. PubMed ID: 23590228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
